Generic Biologics Bill Reintroduced

Law360, New York (February 15, 2007, 12:00 AM EST) -- A bipartisan group of legislators reintroduced a bill Wednesday that would provide a way for generic versions of biologic drugs to receive regulatory approval and be marketed to consumers.

The bill, which is identical to one proposed last year, would give the U.S. Food and Drug Administration the discretion to decide when it is scientifically appropriate to approve a generic of a biologic or biotech drug.

The legislation was introduced in both the U.S. House of Representatives and the U.S. Senate, and was sponsored by Reps....
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.